Evolving HPV diagnostics: current practice and future frontiers Article Swipe
Lin Shi
,
Haizhen Chen
,
Zichen Zhang
,
Yifei Wang
,
Wenbo Ren
,
Jing Huang
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fcimb.2025.1681779
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fcimb.2025.1681779
Human papillomavirus (HPV) infection serves as a primary causative agent of cervical cancer, highlighting the importance of early screening and detection in mitigating the incidence and mortality rates of HPV-related diseases. Over the past decades, HPV detection technologies have evolved considerably, transitioning from traditional methods to more advanced, patient-centered approaches. This review provides a comprehensive overview of both established and emerging HPV detection strategies, with a particular focus on their clinical applicability, technical advantages, and limitations. Conventional methods such as hybrid capture and PCR-based assays remain the backbone of clinical screening, offering robust sensitivity and specificity. However, their reliance on invasive sampling and centralized laboratory infrastructure limits accessibility and patient compliance, particularly in low-resource settings. To address these limitations, emerging technologies—including CRISPR/Cas systems, droplet digital PCR (ddPCR), next-generation sequencing (NGS), isothermal amplification techniques (IAT) and artificial intelligence (AI) combined with hpv screening offer enhanced accuracy, rapid turnaround, and the potential for point-of-care deployment. In parallel, innovations in sampling such as self-collected vaginal swabs and liquid biopsy using urine, blood, or extracellular vesicles are improving test acceptability and broadening screening coverage. By summarizing current progress and highlighting ongoing challenges, this review aims to guide the development of more precise, non-invasive, and scalable HPV detection strategies to reduce the global burden of HPV-related disease, support global prevention efforts, and guide public health policies.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fcimb.2025.1681779
- https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdf
- OA Status
- gold
- References
- 95
- OpenAlex ID
- https://openalex.org/W4416099220
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416099220Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fcimb.2025.1681779Digital Object Identifier
- Title
-
Evolving HPV diagnostics: current practice and future frontiersWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-11Full publication date if available
- Authors
-
Lin Shi, Haizhen Chen, Zichen Zhang, Yifei Wang, Wenbo Ren, Jing HuangList of authors in order
- Landing page
-
https://doi.org/10.3389/fcimb.2025.1681779Publisher landing page
- PDF URL
-
https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
95Number of works referenced by this work
Full payload
| id | https://openalex.org/W4416099220 |
|---|---|
| doi | https://doi.org/10.3389/fcimb.2025.1681779 |
| ids.doi | https://doi.org/10.3389/fcimb.2025.1681779 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41306592 |
| ids.openalex | https://openalex.org/W4416099220 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000175 |
| mesh[1].descriptor_ui | D030361 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | diagnosis |
| mesh[1].descriptor_name | Papillomavirus Infections |
| mesh[2].qualifier_ui | Q000821 |
| mesh[2].descriptor_ui | D030361 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | virology |
| mesh[2].descriptor_name | Papillomavirus Infections |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | Q000379 |
| mesh[4].descriptor_ui | D025202 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | methods |
| mesh[4].descriptor_name | Molecular Diagnostic Techniques |
| mesh[5].qualifier_ui | Q000639 |
| mesh[5].descriptor_ui | D025202 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | trends |
| mesh[5].descriptor_name | Molecular Diagnostic Techniques |
| mesh[6].qualifier_ui | Q000235 |
| mesh[6].descriptor_ui | D027383 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | genetics |
| mesh[6].descriptor_name | Papillomaviridae |
| mesh[7].qualifier_ui | Q000302 |
| mesh[7].descriptor_ui | D027383 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | isolation & purification |
| mesh[7].descriptor_name | Papillomaviridae |
| mesh[8].qualifier_ui | Q000821 |
| mesh[8].descriptor_ui | D002583 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | virology |
| mesh[8].descriptor_name | Uterine Cervical Neoplasms |
| mesh[9].qualifier_ui | Q000175 |
| mesh[9].descriptor_ui | D002583 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | diagnosis |
| mesh[9].descriptor_name | Uterine Cervical Neoplasms |
| mesh[10].qualifier_ui | Q000379 |
| mesh[10].descriptor_ui | D055088 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | methods |
| mesh[10].descriptor_name | Early Detection of Cancer |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D059014 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | High-Throughput Nucleotide Sequencing |
| mesh[12].qualifier_ui | Q000379 |
| mesh[12].descriptor_ui | D021141 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | methods |
| mesh[12].descriptor_name | Nucleic Acid Amplification Techniques |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D012680 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Sensitivity and Specificity |
| mesh[14].qualifier_ui | Q000379 |
| mesh[14].descriptor_ui | D016133 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | methods |
| mesh[14].descriptor_name | Polymerase Chain Reaction |
| mesh[15].qualifier_ui | Q000379 |
| mesh[15].descriptor_ui | D008403 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | methods |
| mesh[15].descriptor_name | Mass Screening |
| type | article |
| title | Evolving HPV diagnostics: current practice and future frontiers |
| biblio.issue | |
| biblio.volume | 15 |
| biblio.last_page | 1681779 |
| biblio.first_page | 1681779 |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| language | en |
| locations[0].id | doi:10.3389/fcimb.2025.1681779 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2506667490 |
| locations[0].source.issn | 2235-2988 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2235-2988 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Cellular and Infection Microbiology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Cellular and Infection Microbiology |
| locations[0].landing_page_url | https://doi.org/10.3389/fcimb.2025.1681779 |
| locations[1].id | pmid:41306592 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in cellular and infection microbiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41306592 |
| locations[2].id | pmh:oai:doaj.org/article:c427164f3b45455487439796ea5dc828 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Cellular and Infection Microbiology, Vol 15 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/c427164f3b45455487439796ea5dc828 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5083198436 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7578-7440 |
| authorships[0].author.display_name | Lin Shi |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210125137 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[0].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[0].institutions[0].ror | https://ror.org/034haf133 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | First Hospital of Jilin University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Lin Shi |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[1].author.id | https://openalex.org/A5063415608 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9663-9607 |
| authorships[1].author.display_name | Haizhen Chen |
| authorships[1].countries | CN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210125137 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[1].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[1].institutions[0].ror | https://ror.org/034haf133 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[1].institutions[0].country_code | CN |
| authorships[1].institutions[0].display_name | First Hospital of Jilin University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Haizhen Chen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[2].author.id | https://openalex.org/A5045125356 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Zichen Zhang |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210125137 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[2].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[2].institutions[0].ror | https://ror.org/034haf133 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | First Hospital of Jilin University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Zichen Zhang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[3].author.id | https://openalex.org/A5100365600 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-9918-2865 |
| authorships[3].author.display_name | Yifei Wang |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I121691239 |
| authorships[3].affiliations[0].raw_affiliation_string | College of Medical Technology, Beihua University, Jilin, China |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I4210125137 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[3].institutions[0].id | https://openalex.org/I121691239 |
| authorships[3].institutions[0].ror | https://ror.org/013jjp941 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I121691239 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Beihua University |
| authorships[3].institutions[1].id | https://openalex.org/I4210125137 |
| authorships[3].institutions[1].ror | https://ror.org/034haf133 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210125137 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | First Hospital of Jilin University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Yifei Wang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | College of Medical Technology, Beihua University, Jilin, China, Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[4].author.id | https://openalex.org/A5102867735 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2167-590X |
| authorships[4].author.display_name | Wenbo Ren |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210125137 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[4].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[4].institutions[0].ror | https://ror.org/034haf133 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | First Hospital of Jilin University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Wenbo Ren |
| authorships[4].is_corresponding | True |
| authorships[4].raw_affiliation_strings | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[5].author.id | https://openalex.org/A5101688859 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8150-7123 |
| authorships[5].author.display_name | Jing Huang |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210125137 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| authorships[5].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[5].institutions[0].ror | https://ror.org/034haf133 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | First Hospital of Jilin University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Jing Huang |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, China |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-11T00:00:00 |
| display_name | Evolving HPV diagnostics: current practice and future frontiers |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T23:14:17.795251 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.3389/fcimb.2025.1681779 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2506667490 |
| best_oa_location.source.issn | 2235-2988 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2235-2988 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Cellular and Infection Microbiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Cellular and Infection Microbiology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fcimb.2025.1681779 |
| primary_location.id | doi:10.3389/fcimb.2025.1681779 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2506667490 |
| primary_location.source.issn | 2235-2988 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2235-2988 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Cellular and Infection Microbiology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://public-pages-files-2025.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1681779/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Cellular and Infection Microbiology |
| primary_location.landing_page_url | https://doi.org/10.3389/fcimb.2025.1681779 |
| publication_date | 2025-11-11 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4210828652, https://openalex.org/W4210255733, https://openalex.org/W1998567451, https://openalex.org/W2763451507, https://openalex.org/W4283066641, https://openalex.org/W3121560820, https://openalex.org/W4221027963, https://openalex.org/W2121723457, https://openalex.org/W2984664409, https://openalex.org/W3003249044, https://openalex.org/W2131255017, https://openalex.org/W2282885010, https://openalex.org/W1840190091, https://openalex.org/W2097038409, https://openalex.org/W2985532529, https://openalex.org/W4405516584, https://openalex.org/W4406823739, https://openalex.org/W1876440733, https://openalex.org/W2289646811, https://openalex.org/W4410897392, https://openalex.org/W4401245492, https://openalex.org/W3045996770, https://openalex.org/W4391772481, https://openalex.org/W4311180794, https://openalex.org/W4280565162, https://openalex.org/W2128222572, https://openalex.org/W2786972406, https://openalex.org/W2159007127, https://openalex.org/W2071793902, https://openalex.org/W4388724082, https://openalex.org/W1586776409, https://openalex.org/W4408051737, https://openalex.org/W2407334617, https://openalex.org/W2146652759, https://openalex.org/W2153720421, https://openalex.org/W1729453366, https://openalex.org/W3203745840, https://openalex.org/W4403547644, https://openalex.org/W4395676193, https://openalex.org/W4403853942, https://openalex.org/W1981725818, https://openalex.org/W4378087412, https://openalex.org/W4389266482, https://openalex.org/W2157829177, https://openalex.org/W3024886931, https://openalex.org/W2589694509, https://openalex.org/W2737123810, https://openalex.org/W4392595696, https://openalex.org/W3162422516, https://openalex.org/W2775577970, https://openalex.org/W4221083222, https://openalex.org/W2126997151, https://openalex.org/W1990063932, https://openalex.org/W2073474887, https://openalex.org/W2171458488, https://openalex.org/W4396801551, https://openalex.org/W3211534828, https://openalex.org/W4385666674, https://openalex.org/W2910709065, https://openalex.org/W2109680788, https://openalex.org/W2132203954, https://openalex.org/W2070117992, https://openalex.org/W2789736722, https://openalex.org/W2121732950, https://openalex.org/W2559124996, https://openalex.org/W2085612259, https://openalex.org/W4400217827, https://openalex.org/W3215359719, https://openalex.org/W4361268782, https://openalex.org/W3002413794, https://openalex.org/W2768396402, https://openalex.org/W2067283343, https://openalex.org/W3093048084, https://openalex.org/W4414803283, https://openalex.org/W3187931965, https://openalex.org/W2001179033, https://openalex.org/W2996282369, https://openalex.org/W4414563909, https://openalex.org/W4386191581, https://openalex.org/W4285745177, https://openalex.org/W2103938573, https://openalex.org/W2054699952, https://openalex.org/W4396834752, https://openalex.org/W2889779167, https://openalex.org/W4404589254, https://openalex.org/W3128429908, https://openalex.org/W2137172372, https://openalex.org/W4324363970, https://openalex.org/W3094306136, https://openalex.org/W4302286426, https://openalex.org/W4200617322, https://openalex.org/W2794182515, https://openalex.org/W4388569106, https://openalex.org/W2943655044, https://openalex.org/W4310458525 |
| referenced_works_count | 95 |
| abstract_inverted_index.a | 6, 53, 65 |
| abstract_inverted_index.By | 180 |
| abstract_inverted_index.In | 153 |
| abstract_inverted_index.To | 115 |
| abstract_inverted_index.as | 5, 79, 159 |
| abstract_inverted_index.in | 21, 112, 156 |
| abstract_inverted_index.of | 10, 16, 28, 56, 88, 195, 209 |
| abstract_inverted_index.on | 68, 99 |
| abstract_inverted_index.or | 169 |
| abstract_inverted_index.to | 45, 191, 204 |
| abstract_inverted_index.HPV | 35, 61, 201 |
| abstract_inverted_index.PCR | 125 |
| abstract_inverted_index.and | 19, 25, 59, 74, 82, 94, 102, 108, 134, 147, 163, 176, 184, 199, 216 |
| abstract_inverted_index.are | 172 |
| abstract_inverted_index.for | 150 |
| abstract_inverted_index.hpv | 140 |
| abstract_inverted_index.the | 14, 23, 32, 86, 148, 193, 206 |
| abstract_inverted_index.(AI) | 137 |
| abstract_inverted_index.Over | 31 |
| abstract_inverted_index.This | 50 |
| abstract_inverted_index.aims | 190 |
| abstract_inverted_index.both | 57 |
| abstract_inverted_index.from | 42 |
| abstract_inverted_index.have | 38 |
| abstract_inverted_index.more | 46, 196 |
| abstract_inverted_index.past | 33 |
| abstract_inverted_index.such | 78, 158 |
| abstract_inverted_index.test | 174 |
| abstract_inverted_index.this | 188 |
| abstract_inverted_index.with | 64, 139 |
| abstract_inverted_index.(HPV) | 2 |
| abstract_inverted_index.(IAT) | 133 |
| abstract_inverted_index.Human | 0 |
| abstract_inverted_index.agent | 9 |
| abstract_inverted_index.early | 17 |
| abstract_inverted_index.focus | 67 |
| abstract_inverted_index.guide | 192, 217 |
| abstract_inverted_index.offer | 142 |
| abstract_inverted_index.rapid | 145 |
| abstract_inverted_index.rates | 27 |
| abstract_inverted_index.swabs | 162 |
| abstract_inverted_index.their | 69, 97 |
| abstract_inverted_index.these | 117 |
| abstract_inverted_index.using | 166 |
| abstract_inverted_index.(NGS), | 129 |
| abstract_inverted_index.assays | 84 |
| abstract_inverted_index.biopsy | 165 |
| abstract_inverted_index.blood, | 168 |
| abstract_inverted_index.burden | 208 |
| abstract_inverted_index.global | 207, 213 |
| abstract_inverted_index.health | 219 |
| abstract_inverted_index.hybrid | 80 |
| abstract_inverted_index.limits | 106 |
| abstract_inverted_index.liquid | 164 |
| abstract_inverted_index.public | 218 |
| abstract_inverted_index.reduce | 205 |
| abstract_inverted_index.remain | 85 |
| abstract_inverted_index.review | 51, 189 |
| abstract_inverted_index.robust | 92 |
| abstract_inverted_index.serves | 4 |
| abstract_inverted_index.urine, | 167 |
| abstract_inverted_index.address | 116 |
| abstract_inverted_index.cancer, | 12 |
| abstract_inverted_index.capture | 81 |
| abstract_inverted_index.current | 182 |
| abstract_inverted_index.digital | 124 |
| abstract_inverted_index.droplet | 123 |
| abstract_inverted_index.evolved | 39 |
| abstract_inverted_index.methods | 44, 77 |
| abstract_inverted_index.ongoing | 186 |
| abstract_inverted_index.patient | 109 |
| abstract_inverted_index.primary | 7 |
| abstract_inverted_index.support | 212 |
| abstract_inverted_index.vaginal | 161 |
| abstract_inverted_index.(ddPCR), | 126 |
| abstract_inverted_index.However, | 96 |
| abstract_inverted_index.backbone | 87 |
| abstract_inverted_index.cervical | 11 |
| abstract_inverted_index.clinical | 70, 89 |
| abstract_inverted_index.combined | 138 |
| abstract_inverted_index.decades, | 34 |
| abstract_inverted_index.disease, | 211 |
| abstract_inverted_index.efforts, | 215 |
| abstract_inverted_index.emerging | 60, 119 |
| abstract_inverted_index.enhanced | 143 |
| abstract_inverted_index.invasive | 100 |
| abstract_inverted_index.offering | 91 |
| abstract_inverted_index.overview | 55 |
| abstract_inverted_index.precise, | 197 |
| abstract_inverted_index.progress | 183 |
| abstract_inverted_index.provides | 52 |
| abstract_inverted_index.reliance | 98 |
| abstract_inverted_index.sampling | 101, 157 |
| abstract_inverted_index.scalable | 200 |
| abstract_inverted_index.systems, | 122 |
| abstract_inverted_index.vesicles | 171 |
| abstract_inverted_index.PCR-based | 83 |
| abstract_inverted_index.accuracy, | 144 |
| abstract_inverted_index.advanced, | 47 |
| abstract_inverted_index.causative | 8 |
| abstract_inverted_index.coverage. | 179 |
| abstract_inverted_index.detection | 20, 36, 62, 202 |
| abstract_inverted_index.diseases. | 30 |
| abstract_inverted_index.improving | 173 |
| abstract_inverted_index.incidence | 24 |
| abstract_inverted_index.infection | 3 |
| abstract_inverted_index.mortality | 26 |
| abstract_inverted_index.parallel, | 154 |
| abstract_inverted_index.policies. | 220 |
| abstract_inverted_index.potential | 149 |
| abstract_inverted_index.screening | 18, 141, 178 |
| abstract_inverted_index.settings. | 114 |
| abstract_inverted_index.technical | 72 |
| abstract_inverted_index.CRISPR/Cas | 121 |
| abstract_inverted_index.artificial | 135 |
| abstract_inverted_index.broadening | 177 |
| abstract_inverted_index.importance | 15 |
| abstract_inverted_index.isothermal | 130 |
| abstract_inverted_index.laboratory | 104 |
| abstract_inverted_index.mitigating | 22 |
| abstract_inverted_index.particular | 66 |
| abstract_inverted_index.prevention | 214 |
| abstract_inverted_index.screening, | 90 |
| abstract_inverted_index.sequencing | 128 |
| abstract_inverted_index.strategies | 203 |
| abstract_inverted_index.techniques | 132 |
| abstract_inverted_index.HPV-related | 29, 210 |
| abstract_inverted_index.advantages, | 73 |
| abstract_inverted_index.approaches. | 49 |
| abstract_inverted_index.centralized | 103 |
| abstract_inverted_index.challenges, | 187 |
| abstract_inverted_index.compliance, | 110 |
| abstract_inverted_index.deployment. | 152 |
| abstract_inverted_index.development | 194 |
| abstract_inverted_index.established | 58 |
| abstract_inverted_index.innovations | 155 |
| abstract_inverted_index.sensitivity | 93 |
| abstract_inverted_index.strategies, | 63 |
| abstract_inverted_index.summarizing | 181 |
| abstract_inverted_index.traditional | 43 |
| abstract_inverted_index.turnaround, | 146 |
| abstract_inverted_index.Conventional | 76 |
| abstract_inverted_index.highlighting | 13, 185 |
| abstract_inverted_index.intelligence | 136 |
| abstract_inverted_index.limitations, | 118 |
| abstract_inverted_index.limitations. | 75 |
| abstract_inverted_index.low-resource | 113 |
| abstract_inverted_index.particularly | 111 |
| abstract_inverted_index.specificity. | 95 |
| abstract_inverted_index.technologies | 37 |
| abstract_inverted_index.acceptability | 175 |
| abstract_inverted_index.accessibility | 107 |
| abstract_inverted_index.amplification | 131 |
| abstract_inverted_index.comprehensive | 54 |
| abstract_inverted_index.considerably, | 40 |
| abstract_inverted_index.extracellular | 170 |
| abstract_inverted_index.non-invasive, | 198 |
| abstract_inverted_index.point-of-care | 151 |
| abstract_inverted_index.transitioning | 41 |
| abstract_inverted_index.applicability, | 71 |
| abstract_inverted_index.infrastructure | 105 |
| abstract_inverted_index.papillomavirus | 1 |
| abstract_inverted_index.self-collected | 160 |
| abstract_inverted_index.next-generation | 127 |
| abstract_inverted_index.patient-centered | 48 |
| abstract_inverted_index.technologies—including | 120 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5102867735, https://openalex.org/A5101688859 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I4210125137 |
| citation_normalized_percentile |